Your browser doesn't support javascript.
loading
Artificial intelligence and real-world data for drug and food safety - A regulatory science perspective.
Thakkar, Shraddha; Slikker, William; Yiannas, Frank; Silva, Primal; Blais, Burton; Chng, Kern Rei; Liu, Zhichao; Adholeya, Alok; Pappalardo, Francesco; Soares, Mônica da Luz Carvalho; Beeler, Patrick E; Whelan, Maurice; Roberts, Ruth; Borlak, Jurgen; Hugas, Martha; Torrecilla-Salinas, Carlos; Girard, Philippe; Diamond, Matthew C; Verloo, Didier; Panda, Binay; Rose, Miquella C; Jornet, Joaquim Berenguer; Furuhama, Ayako; Fang, Hong; Kwegyir-Afful, Ernest; Heintz, Kasey; Arvidson, Kirk; Burgos, Juan Garcia; Horst, Alexander; Tong, Weida.
  • Thakkar S; Center for Drug Evaluations and Research (CDER), Food and Drug Administration (FDA), USA.
  • Slikker W; National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.
  • Yiannas F; Food and Drug Administration (FDA), USA.
  • Silva P; Canadian Food Inspection Agency (CFIA), Canada.
  • Blais B; Canadian Food Inspection Agency (CFIA), Canada.
  • Chng KR; National Centre for Food Science, Singapore Food Agency (SFA), Singapore.
  • Liu Z; National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.
  • Adholeya A; The Energy and Resources Institute (TERI), New Delhi, India.
  • Pappalardo F; University of Catania, Italy.
  • Soares MDLC; Brazilian Health Regulatory Agency (ANVISA), Brazil.
  • Beeler PE; Swissmedic, Bern, Switzerland; University of Zurich, Zurich, Switzerland.
  • Whelan M; Joint Research Center (JRC), Spain.
  • Roberts R; Apconix, UK.
  • Borlak J; Hannover Medical School, Germany.
  • Hugas M; European Food Safety Authority (EFSA), Italy.
  • Torrecilla-Salinas C; Joint Research Center (JRC), Spain.
  • Girard P; Swissmedic, Bern, Switzerland.
  • Diamond MC; Center for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA), USA.
  • Verloo D; European Food Safety Authority (EFSA), Italy.
  • Panda B; Jawaharlal Nehru University (JNU), New Delhi, India.
  • Rose MC; Burroughs Wellcome Fund (BWF), USA.
  • Jornet JB; European Medical Agency (EMA), the Netherlands.
  • Furuhama A; National Institute of Health Sciences (NIHS), Japan.
  • Fang H; National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.
  • Kwegyir-Afful E; Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.
  • Heintz K; Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.
  • Arvidson K; Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.
  • Burgos JG; European Medical Agency (EMA), the Netherlands.
  • Horst A; Swissmedic, Bern, Switzerland.
  • Tong W; National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA. Electronic address: Weida.tong@fda.hhs.gov.
Regul Toxicol Pharmacol ; 140: 105388, 2023 05.
Article en En | MEDLINE | ID: mdl-37061083
ABSTRACT
In 2013, the Global Coalition for Regulatory Science Research (GCRSR) was established with members from over ten countries (www.gcrsr.net). One of the main objectives of GCRSR is to facilitate communication among global regulators on the rise of new technologies with regulatory applications through the annual conference Global Summit on Regulatory Science (GSRS). The 11th annual GSRS conference (GSRS21) focused on "Regulatory Sciences for Food/Drug Safety with Real-World Data (RWD) and Artificial Intelligence (AI)." The conference discussed current advancements in both AI and RWD approaches with a specific emphasis on how they impact regulatory sciences and how regulatory agencies across the globe are pursuing the adaptation and oversight of these technologies. There were presentations from Brazil, Canada, India, Italy, Japan, Germany, Switzerland, Singapore, the United Kingdom, and the United States. These presentations highlighted how various agencies are moving forward with these technologies by either improving the agencies' operation and/or preparing regulatory mechanisms to approve the products containing these innovations. To increase the content and discussion, the GSRS21 hosted two debate sessions on the question of "Is Regulatory Science Ready for AI?" and a workshop to showcase the analytical data tools that global regulatory agencies have been using and/or plan to apply to regulatory science. Several key topics were highlighted and discussed during the conference, such as the capabilities of AI and RWD to assist regulatory science policies for drug and food safety, the readiness of AI and data science to provide solutions for regulatory science. Discussions highlighted the need for a constant effort to evaluate emerging technologies for fit-for-purpose regulatory applications. The annual GSRS conferences offer a unique platform to facilitate discussion and collaboration across regulatory agencies, modernizing regulatory approaches, and harmonizing efforts.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inteligencia Artificial / Inocuidad de los Alimentos País como asunto: America do norte / Europa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inteligencia Artificial / Inocuidad de los Alimentos País como asunto: America do norte / Europa Idioma: En Año: 2023 Tipo del documento: Article